Immunoreactivity of Sera From Low to Moderate Malaria-Endemic Areas Against Plasmodium vivax r Pvs 48/45 Proteins Produced in Escherichia coli and Chinese Hamster Ovary Systems

Front Immunol. 2021 Jun 24:12:634738. doi: 10.3389/fimmu.2021.634738. eCollection 2021.

Abstract

P48/45 is a conserved gametocyte antigen involved in Plasmodium parasite fertilization. A recombinant Plasmodium vivax P48/45 (Pvs48/45) protein expressed in Escherichia coli (E. coli) was highly antigenic and immunogenic in experimental animals and elicited specific transmission-blocking (TB) antibodies in a previous pilot study. Here, a similar Pvs48/45 gene was expressed in Chinese Hamster Ovary (CHO) cells and we compared its immunoreactivity with the E. coli product. Specific antibody titers were determined using plasma from Colombian individuals (n=227) living in endemic areas where both P. vivax and P. falciparum are prevalent and from Guatemala (n=54) where P. vivax is highly prevalent. In Colombia, plasma seroprevalence to CHO-rPvs48/45 protein was 46.3%, while for E. coli-rPvs48/45 protein was 36.1% (p<0.001). In Guatemala, the sero prevalence was 24.1% and 14.8% (p<0.001), respectively. Reactivity index (RI) against both proteins showed an age-dependent increase. IgG2 was the predominant subclass and the antibody avidity index evaluated by ELISA ranged between 4-6 mol/L. Ex vivo P. vivax mosquito direct membrane feeding assays (DMFA) performed in presence of study plasmas, displayed significant parasite transmission-blocking (TB), however, there was no direct correlation between antibody titers and oocysts transmission reduction activity (%TRA). Nevertheless, DMFA with CHO rPvs48/45 affinity purified IgG showed a dose response; 90.2% TRA at 100 μg/mL and 71.8% inhibition at 10 μg/mL. In conclusion, the CHO-rPvs48/45 protein was more immunoreactive in most of the malaria endemic places studied, and CHO-rPvs48/45 specific IgG showed functional activity, supporting further testing of the protein vaccine potential.

Keywords: Plasmodium vivax; Pvs48/45; gametocytes; malaria; transmission blocking; vaccines.

Publication types

  • Comparative Study
  • Multicenter Study
  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Animals
  • Antibodies, Protozoan / blood*
  • Antibody Specificity
  • Antigens, Protozoan / genetics
  • Antigens, Protozoan / immunology*
  • Antigens, Protozoan / metabolism
  • CHO Cells
  • Child
  • Colombia / epidemiology
  • Cricetulus
  • Endemic Diseases*
  • Escherichia coli / genetics
  • Escherichia coli / metabolism*
  • Female
  • Guatemala / epidemiology
  • Humans
  • Immunoglobulin G / blood*
  • Malaria, Vivax / blood
  • Malaria, Vivax / diagnosis*
  • Malaria, Vivax / epidemiology
  • Malaria, Vivax / immunology
  • Male
  • Middle Aged
  • Plasmodium vivax / immunology*
  • Plasmodium vivax / pathogenicity
  • Predictive Value of Tests
  • Recombinant Proteins / immunology
  • Recombinant Proteins / metabolism
  • Seroepidemiologic Studies
  • Serologic Tests*
  • Young Adult

Substances

  • Antibodies, Protozoan
  • Antigens, Protozoan
  • Immunoglobulin G
  • Recombinant Proteins